Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-20

Study Completion Date

2020-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

COVID-19 outbreak is often lethal. Mortality has been associated with several cardio-vascular risk factors such as diabetes, obesity, hypertension and tobacco use. Other clinico-biological features predictive of mortality or transfer to Intensive Care Unit are also needed. Cases of myocarditis have also been reported with COVID-19.

Cardio-vascular events have possibly been highly underestimated. The study proposes to systematically collect cardio-vascular data to study the incidence of myocarditis and coronaropathy events during COVID-19 infection.We will also assess predictive factors for transfer in Intensive Care Unit or death.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cardiac Dysfunction in Critically Ill Patients With COVID-19

NCT04524234

Covid19 Left Ventricular Dysfunction Right Ventricular Dysfunction +1 more

COMPLETED

Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19）

NCT04352842

Covid19 Echocardiography

COMPLETED

Echocardiography in Patients With Covid-19

NCT04412460

COVID ARDS, Human

WITHDRAWN

Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data.

NCT05942729

Hypertension Arterial Hypokinetic Cardiomyopathies +1 more

RECRUITING

Magnetocardiography (MCG) Parameters in the Prediction of Future ICD Therapy

NCT04352816

Death, Sudden, Cardiac Ventricular Arrythmia

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Myocardial Injury Myocarditis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COVID-19 patients

Patients diagnosed with COVID-19 by PCR done on nasal sample.

Electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care

Intervention Type DIAGNOSTIC_TEST

* 12 derivations electrocardiogram done at baseline and repeated every 3 days
* transthoracic echocardiography at baseline
* clinical features at baseline: WHO performans status comorbidities and treatments
* biological results in routine care, such as baseline full blood count, inflammation markers: C-reactive protein, procalcitonin, interleukin-6 and ferritin, coagulation and troponin and brain natriuretic peptide

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care

* 12 derivations electrocardiogram done at baseline and repeated every 3 days
* transthoracic echocardiography at baseline
* clinical features at baseline: WHO performans status comorbidities and treatments
* biological results in routine care, such as baseline full blood count, inflammation markers: C-reactive protein, procalcitonin, interleukin-6 and ferritin, coagulation and troponin and brain natriuretic peptide

Intervention Type DIAGNOSTIC_TEST